NCT03936335View on ClinicalTrials.gov

An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis (AD)

RecruitingOBSERVATIONAL
Enrollment

3,930

Participants

Timeline

Start Date

September 30, 2019

Primary Completion Date

January 21, 2027

Study Completion Date

January 21, 2027

Conditions
Adverse Pregnancy OutcomesAtopic Dermatitis
Interventions
DRUG

dupilumab

No study drug will be administered. This study is based on an analysis of automated medical and prescription claims, supplemented by information abstracted from the medical record.

Trial Locations (1)

02215

RECRUITING

Regeneron Research Site, Boston

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

Regeneron Pharmaceuticals

INDUSTRY

NCT03936335 - An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis (AD) | Biotech Hunter | Biotech Hunter